Maria Forss
BICO’s 3rd Exit Under CEO Maria Forss: MatTek and Visikol to be Sold for $80M
BICO (STO: BICO) is selling two of its companies—MatTek and Visikol—to Sartorius (ETR: SRT3) for $80 million. The decision is part of BICO’s plan to focus on what it sees…
BICO’s €26M Nanoscribe Sale Highlights Strategic Overhaul Under Forss
BICO (STO: BICO) announced its second divestiture since Maria Forss took over as President and CEO in November 2023. Following the sale of Ginolis last year, BICO has now entered…
Big Changes at BICO: Founders Leave as Whistleblower Revelations Spark Overhaul
In a significant development at BICO (STO: BICO), founders Erik Gatenholm and Hector Martinez have decided to leave the company after eight years, marking the end of an era for…
Exclusive Interview: BICO’s New Bioprinting Era under Maria Forss Begins
In the dynamic landscape of life sciences, Maria Forss has taken the helm as the new CEO of BICO (STO: BICO), a name that emerged from bioprinting pioneer Cellink and…
BICO’s Revival: A Fresh Era with Maria Forss at the Helm
Swedish biotech company BICO (STO: BICO) has been making waves in the industry recently. Ever since Maria Forss assumed the role of CEO in November 2023, the company seems to…
BICO’s Path to Profitability is A Test for New CEO Maria Forss
Sharing two key announcements that could signal a new direction, bioscience and bioprinting firm BICO (STO: BICO) has appointed Maria Forss as its new President and CEO. As a demonstration…
